text: Disorders in mtFASII lead to the following metabolic diseases: 
  * ACSF3: Combined malonic and methylmalonic aciduria (CMAMMA)
  * MCAT: Medium-chain acyl-CoA dehydrogenase deficiency (MCAD) 
  * MECR: Mitochondrial enoyl-CoA reductase protein-associated neurodegeneration (MEPAN)